Drug intelligence / Profile preview

Alzyn

Development stage
Unknown
Lead developer
Alzyn
Modality
Small Molecules
Administration
Oral, Transdermal
01

Overview

Alzyn is a patented nutraceutical supplement developed by Alzyn Pharmaceuticals (Alzyn LLC) in collaboration with the Florida State University College of Medicine. The formulation is a combination of Vitamin B-12, epigallocatechin gallate (EGCG), melatonin, and resveratrol, designed to support brain health, enhance immunity, and improve sleep quality. It is specifically marketed to combat memory loss through a nutrigenomics approach. While the company initially focused on a transdermal delivery system to address malabsorption issues in older populations, an oral formulation was subsequently developed in partnership with Young Living Essential Oils. The product is positioned as a science-based dietary supplement rather than a traditional pharmaceutical drug.

Brand names
Alzyn
02

Targets

SIRT1 (NAD-dependent protein deacetylase sirtuin-1)MTNR1A (MT1)

Beyond the preview

Go deeper on Alzyn.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alzyn.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call